Search results for:
Ondine commences first NHS Steriwave® pilot
First NHS pilot of nasal photodisinfection for the prevention of post-surgical infections starts at Mid Yorkshire Teaching NHS Trust Vancouver, British Columbia, Canada - August 1, 2023 The pilot will assess the effect of nasal photodisinfection on 500 elective surgery patients at Pontefract Hospital Mid [...]
Ondine receives Impact Award at IPA World Congress
Ondine Biomedical is recipient of the TAYYABA HASAN IMPACT AWARD at 18th IPA World Congress, Finland Vancouver, British Columbia, Canada - July 17, 2023 Ondine Biomedical (LON:OBI) was awarded the TAYYABA HASAN IMPACT AWARD at the 18th World Congress of International Photodynamic Association (IPA) [...]
Photodisinfection cuts COVID in meat processing plant
Newly published results show treatment with Ondine’s nasal photodisinfection dramatically reduced COVID-19 rates at Canadian meat processing plant Vancouver, British Columbia, Canada - June 22, 2023 (updated with corrections August 16, 2023) Weekly nasal photodisinfection of 1,500 workers in a meat processing plant in [...]
Ondine appoints senior pharma exec as Chief Medical Officer
Ondine Biomedical appoints senior pharma executive Dr. Simon Sinclair as Chief Medical Officer Vancouver, British Columbia, Canada - June 1, 2023 Canadian life sciences company Ondine Biomedical has appointed Dr. Simon Sinclair as Chief Medical Officer, as the Company prepares to start the US [...]
Ondine reports successful food pathogen study
Ondine Biomedical reports photodisinfection is highly effective against key food-borne pathogens Vancouver, British Columbia, Canada - April 20, 2023 Photodisinfection achieved complete elimination (>99.999% kill) against Salmonella enterica and 99.999% reduction of MRSA biofilm – exceeding food safety requirements Successful program made possible by [...]
Ondine Biomedical’s nasal photodisinfection cuts surgical site infections by 66%
Ondine Biomedical’s nasal photodisinfection cuts surgical site infections by 66% Vancouver, British Columbia, Canada - April 18, 2023 Routine pre-surgical use of nasal photodisinfection could prevent tens of thousands of surgical site infections a year in the US alone[i] Ondine Biomedical Inc. (LON: OBI) [...]
Ondine food-safe photodisinfection update
Ondine Biomedical to share meaty results on food-safe photodisinfection technology Vancouver, British Columbia, Canada - April 5, 2023 Canadian life sciences company, Ondine Biomedical, has concluded the first development phase of a new food-safe photodisinfection technology for Canada’s meat packing industry. The findings which will [...]
Ottawa hospital presents Steriwave study results
Nasal photodisinfection reduces hospital length of stay, readmissions and antibiotic use in substantial study at major Ottawa hospital Vancouver, British Columbia, Canada - March 3, 2023 48% shorter mean length of stay among those treated compared with those not treated (P<0.001) 51% fewer readmissions [...]
Bloomberg articles: Killing Bugs in the Nose
Bloomberg publishes articles on Steriwave™ nasal photodisinfection International - February 24, 2023 Today, Bloomberg published an article in both its newsletter and in Businessweek about Ondine Biomedical’s Steriwave™ nasal photodisinfection: Newsletter: Killing Bugs in the Nose Businessweek: Germ-Zapping Lasers Help Cut Down on Infections [...]
Ondine’s APDT reduces SARS-CoV-2 infectivity
Ondine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivity Vancouver, British Columbia, Canada - January 31, 2023 This is the first randomized, placebo-controlled, single-blind clinical study of Steriwave™ nasal photodisinfection in 75 predominantly vaccinated COVID-19 patients to [...]
For Media Information
Simon Vane Percy
Amanda Bernard
